Jens Onken

Title: Jens Onken: Innovator in Pharmaceutical Compositions

Introduction

Jens Onken is a notable inventor based in Barsinghausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of two patents to his name, Onken's work focuses on enhancing the efficacy of pharmaceutical compositions.

Latest Patents

Onken's latest patents include a process for the manufacture and use of pancreatin micropellet cores. This invention describes a method for creating pancreatin micropellets that are substantially free of synthetic oils. The pharmaceutical composition is designed to deliver pancreatin to the upper portion of the intestine of a mammal, ensuring effective release. Another significant patent is for delayed release pancreatin compositions. This enteric-coated oral dosage form comprises an acid-labile active pharmaceutical ingredient and is free of monomeric phthalic acid esters and synthetic oils. The composition includes an enteric coating with at least one plasticizer and one film-forming agent, providing a novel approach to drug formulation.

Career Highlights

Throughout his career, Jens Onken has worked with prominent companies in the pharmaceutical industry. He has been associated with Abbott Products GmbH and AbbVie Pharmaceuticals GmbH, where he has contributed to various innovative projects. His expertise in pharmaceutical formulations has made him a valuable asset in these organizations.

Collaborations

Onken has collaborated with notable professionals in his field, including George Shlieout and Claus-Juergen Koelln. These collaborations have further enriched his work and contributed to the advancement of pharmaceutical technologies.

Conclusion

Jens Onken's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug delivery systems.